Company INTEGRATE

INTP

US45818D1081

Pharmaceuticals

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

Business description: INTEGRATE

Integrated Pharmaceuticals, Inc. is a development-stage company. As of June 30, 2008, the Company is engaged in the development of clinically active pharmaceutical compounds, including active small molecules and recombinant deoxyribonucleic acid (DNA) technology derived products.

Executive Committee: INTEGRATE

Manager	Title	Age	Since
Brad Nightingale PSD	President	56	-
Luke Zouvas LAW	General Counsel	-	-

See INTEGRATE governance

Company details: INTEGRATE

Integrated Pharmaceuticals, Inc.

5727 East Canyon Ridge North Drive

85331, Cave Creek

Generic Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTEGRATE	-.--%	-.--%	-	-	0
ELI LILLY AND COMPANY	+0.87%	+7.02%	+54.02%	+104.66%	1,116B
JOHNSON & JOHNSON	+0.66%	-2.56%	+32.59%	+61.71%	610B
ABBVIE INC.	+0.60%	+3.06%	+25.59%	+93.52%	501B
MERCK & CO., INC.	+1.28%	+0.75%	+74.80%	+40.86%	358B
ROCHE HOLDING AG	-0.13%	+5.98%	+32.91%	+50.39%	366B
NOVARTIS AG	-0.95%	+4.70%	+19.51%	+43.00%	288B
ASTRAZENECA PLC	-1.98%	+3.73%	-0.86%	+13.43%	261B
AMGEN INC.	+0.12%	+4.84%	+47.04%	+51.62%	235B
GILEAD SCIENCES, INC.	-0.64%	+3.53%	+32.80%	+97.60%	195B
Average	-0.07%	+4.74%	+35.38%	+61.87%	392.98B
Weighted average by Cap.	+0.26%	+4.93%	+39.35%	+71.60%